Skip to main content
Future Journal of Pharmaceutical Sciences
Fig. 5 | Future Journal of Pharmaceutical Sciences

Fig. 5

From: In-silico and in-vitro analysis of novel substituted benzimidazolyl derivatives for antimycobacterial potentials targeting enoyl acyl carrier protein reductase (InhA)

Fig. 5Fig. 5Fig. 5Fig. 5

Ligand–protein contact of lead compounds. A diagram of the detailed interactions between the ligand atoms and the protein residues. In the chosen trajectory (0.00–50.05 nsec), interactions that occur more than 20.0% of the simulation period are displayed. As some residues may have many contacts of a single kind with the same ligand atom, it is feasible to have interactions with > 100%

Back to article page